Health
This is to provide Latest HealthNews around the globe
-
New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
Summary: Oral pills add flexibility; insurance coverage still varies widely, and compounded options remain unapproved. What “Best Semaglutide” Means in 2026 If you’re searching “best semaglutide,” you’re probably not looking for hype—you’re looking for clarity. Most people use “best semaglutide” to mean the best pathway—FDA-approved injection, FDA-approved oral, or compounded access—based on medical eligibility, safety considerations, cost, and monitoring needs.…
Read More » -
The battle for the heart — and health — of the Allegheny National Forest | News, Sports, Jobs
Alexandra Wimley / Pittsburgh Media Partnership Newsroom Dan Albaugh, a third-generation logger, drives away from a logging site in the Allegheny National Forest near Howe Township. Alexandra Wimley / Pittsburgh Media Partnership NewsroomJohn Saf, vice president of Generations Forestry, walks among trees marked to be felled while speaking about forest health on a logging site in the Allegheny National Forest.…
Read More » -
Brain imaging reveals how stimulant drugs improve performance in ADHD
In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: Prescription stimulants, such as Ritalin and Adderall, are widely used to treat attention deficit hyperactivity disorder (ADHD), including in children. In the U.S., about 3.5 million kids ages 3 to 17 take an ADHD medication, a…
Read More » -
As prices rise, women seek affordable insurance for their families : Shots
Cynthia Freeman and her husband Brad Lawrence in their apartment in Brooklyn, NY. Because they work freelance jobs as storytellers and podcasters, they rely on their Affordable Care Act insurance to treat Brad’s newly-diagnosed kidney disease. José A. Alvarado Jr. for NPR hide caption toggle caption José A. Alvarado Jr. for NPR As the clock ticked down on 2025, B.…
Read More » -
3 issues to watch in public health in 2026
We warned you late last year that 2025 was likely to be pretty rock ’n roll. Confession time: We had no idea it would be as cuckoo bananas as it turned out to be. That the administration would summarily terminate most global health aid by shuttering the U.S. Agency for International Development? Completely disrupt grant-funded scientific research around the country?…
Read More » -
Weight-loss drugs are changing. Here’s what to know
NEW YORK – Weight-loss drugs known as GLP-1s are transforming healthcare. Some people who struggled for years to shed pounds experience dramatic weight loss on the medications, and there are indications that the drugs have potential to treat diseases beyond obesity. The drugs also have minted billions of dollars for Eli Lilly and Denmark’s Novo Nordisk, the two pharmaceutical powerhouses…
Read More » -
Stolen medication
As journalists, we measure success not just in clicks or conversions, but in what happens after a story makes its way into the world. Impact isn’t always immediate or easily quantified. It can surface quietly — in an email from a listener, a shift in public understanding, or a decision made differently because someone finally has the information they need.…
Read More » -
She goes to police calls in a Prius. It’s part of a new approach to mental health emergencies
Briana Fair, a mental health clinician with the San Mateo Police Department, received a dozen voicemails from the same distressed caller over a single weekend this month. She knew the voice. It was her client, saying that a celebrity has been hacking her phone, that she needed help moving into a different apartment and why was the process taking so…
Read More » -
Weight-loss drugs are changing. Here’s what to know about GLP-1s
Weight-loss drugs known as GLP-1s are transforming health care. Some people who struggled for years to shed pounds experience dramatic weight loss on the medications, and there are indications that the drugs have potential to treat diseases beyond obesity. The drugs also have minted billions of dollars for Eli Lilly & Co. and Denmark’s Novo Nordisk A/S, the two pharmaceutical…
Read More » -
Rural health providers could be collateral damage from $100K Trump visa fee
By Arielle Zionts and Phillip Reese, Kaiser Health news UNITED STATES — Bekki Holzkamm has been trying to hire a lab technician at a hospital in rural North Dakota since late summer. Not one U.S. citizen has applied. West River Health Services in Hettinger, a town of about 1,000 residents in the southwestern part of the state, has four options, and none is good.…
Read More »
